Human Papillomavirus (HPV) Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study
CONCLUSIONS: Reported use of levonorgestrel intrauterine system and hormonal contraception, but not use of copper IUD, was associated with a higher prevalence of HPV infections and histological HSIL + compared to no reported use of contraception.PMID:38666336 | DOI:10.1080/13625187.2024.2340521 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - April 26, 2024 Category: Reproduction Medicine Authors: Lina Jans Jan Brynhildsen Evin Cherif Linnea Tenerz Lovisa Bergengren Source Type: research

Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics
This study aimed to carry out a literature review considering several aspects involving HPV infection: Global distribution, prevalence, biology, host interactions, cancer development, prevention, therapeutics, coinfection with other viruses, coinfection with bacteria, association with head and neck squamous cell carcinomas, and association with anal cancer.PMID:38666757 | DOI:10.1002/rmv.2537 (Source: Cancer Control)
Source: Cancer Control - April 26, 2024 Category: Cancer & Oncology Authors: Jonas Wolf Lucas Felipe Kist Samanta Brangel Pereira Marilze Alves Quessada Helena Petek Arthur Pille Ju çara Gasparetto Maccari Mohamed Parrini Mutlaq Luiz Antonio Nasi Source Type: research

Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer
CONCLUSIONS: ctHPV DNA in follow-up plasma is a promising prognostic biomarker in patients with LACC, useful for analysis of response to therapy and for early detection of relapse.PMID:38669077 | DOI:10.1158/1078-0432.CCR-23-3941 (Source: Clinical Cancer Research)
Source: Clinical Cancer Research - April 26, 2024 Category: Cancer & Oncology Authors: Lars Sivars Cecilia Jylh ä Ylva Crona Guterstam Mark Zupancic Britta Lindqvist Magnus Nordenskj öld Emma Tham Kristina Hellman Source Type: research

Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting
CONCLUSION: Oping for 2 doses of 9vHPV vaccine in conjunction with a primary HPV screening represents the most cost-effective option for implementing a school-based HPV vaccination program targeting 12-year-old girls in Thailand. Such findings provide valuable insights for policymakers in the realm of cervical cancer prevention.PMID:38670561 | DOI:10.3802/jgo.2024.35.e85 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - April 26, 2024 Category: OBGYN Authors: Wichai Termrungruanglert Nipon Khemapech Apichai Vasuratna Piyalamporn Havanond Tanitra Tantitamit Source Type: research

Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer
CONCLUSIONS: ctHPV DNA in follow-up plasma is a promising prognostic biomarker in patients with LACC, useful for analysis of response to therapy and for early detection of relapse.PMID:38669077 | DOI:10.1158/1078-0432.CCR-23-3941 (Source: Cell Research)
Source: Cell Research - April 26, 2024 Category: Cytology Authors: Lars Sivars Cecilia Jylh ä Ylva Crona Guterstam Mark Zupancic Britta Lindqvist Magnus Nordenskj öld Emma Tham Kristina Hellman Source Type: research